. Cholangiography revealed dilated intrahepatic bile ducts without contrast entering beyond the common hepatic duct.
TAI, we gave 3-dimensional conformal radiation therapy (3DCRT) to the CBD and the intrahepatic metastatic lesion. The prescribed dosage in the target was 3000 cGy, 300 cGy every dose, 5 doses/wk, 10 treatments in total, accomplished over 14 days. During 3DCRT, the patient had intermittent fever, with 41°C as the highest temperature, which was resolved by antibiotic administration. No other obvious adverse effects were observed.
Two weeks after 3DCRT, a cholangiogram revealed further improved patency of CBD, so we used an inner drainage tube to replace the original one. The draining
Case Report
A 59-year-old man was admitted with a complaint of yellow skin and urine for 10 days. Laboratory tests revealed a total bilirubin level of 270.6 µmol/L, direct bilirubin level of 199.2 µmol/L, and an indirect bilirubin level of 71.4 µmol/L. Enhanced computer tomography and magnetic resonance cholangiopancreatography (MRCP) found complete blockage of the common bile duct (CBD) with tumor tissue and an intrahepatic metastatic mass. Percutaneous core biopsy proved histologically cholangiocarcinoma. A percutaneous transhepatic cholangiography and drainage detected dilated intrahepatic ducts, without contrast entering the CBD and the duodenum ( Figure 1 ).
Over 5 months, we performed transcatheter arterial infusion (TAI) of chemical agents to treat the tumor 4 times, at intervals of more than 1 month. The regimen was tegafur 1 g, vinorelbine 40 mg, and cisplatin 80 mg every administration; each was diluted into 40 mL and injected over 20 minutes. One week after the second TAI, a radiogram with contrast through the biliary drainage catheter discovered a small part of the CBD. After the third TAI, contrast could be visualized going via the CBD into the duodenum (Figure 2 ).
After the second and third TAIs, debris was observed in the externally drained bile and proved to be mainly necrotic tissue by pathology. One month after the fourth
Arterial Chemotherapy and Conformal Radiation Abolish Malignant Biliary Obstruction
Yong-Song Guan, MD, Qing He, MD, Ping Li, MD, Yu-Chuan Fu, DEng, and Shao-Wei Zhao, MB Malignant biliary obstruction has been a challenge to clinical practitioners, especially when it is serious and complete. Chemotherapy or radiation alone is often unsuccessful. In this study, the authors report a 59-year-old patient with complete common bile duct obstruction caused by cholangiocarcinoma who was treated with arterial chemotherapy followed by 3-dimensional conformal radiation, which resulted in a good clinical outcome. tube was retained for aspiration of necrotic tissue fragments from the common bile duct when necessary. MRCP demonstrated relief of intrahepatic bile duct dilatation, and the patient was discharged. Followed as an outpatient, he had such examination results as total bilirubin 21.0 µmol/L, direct bilirubin 15.3 µmol/L, patent CBD, and strictured common hepatic duct ( Figure 3 ). Sixteen months have passed since his first admission, and he is now leading a life of self-care with good appetite.
Discussion
Cholangiocarcinoma is difficult both in its diagnosis and treatment, with a very poor prognosis. [1] [2] [3] It is one of the rare malignancies, however, for which the incidence is rising globally 1 : about 0.7 to 1 per 100 000 in Western countries, but much higher in the East. 2 Its pathogenesis has been correlated with various factors as well as to several oncogenes and tumor suppressor genes 4 including the p53 gene 5 and nuclear factor κB. 6 Surgical resection may be curative, but only 10% of the tumors can be resected, 3 with 5-year survival reported as 0% to 39%. 2 Even when resected completely, there is a chance of recurrence leading to therapeutic failure. 7 Radiotherapy has been applied to the unresectable cases, such as intraoperative large-dose radiation, brachytherapy, or conformal radiation, but this needs further investigation. 2 Simultaneous chemotherapy may have synergistic effects on localized advanced lesions. Intensity-modulated radiation therapy and 3-and 4-dimensional treatment planning permit increases in intensity of radiation dose without significant increases in normal tissue toxicity, thereby increasing the effective radiation dose. 7 Preliminary results of studies employing hepatic transplantation with radiation therapy are encouraging. 7 Local failure is a major problem in radiotherapy, suggesting the need for more intense radiation schedules and better radiosensitizing strategies. Because resection with any tumor residues appears to convey no benefit, it appears that surgery should be considered only when a resection is likely complete. Borderline-resectable patients might be better served by neoadjuvant therapy. 8 A phase 2 trial 9 with high-dose radiation and concurrent TAI of floxuridine resulted in prolonged survival in patients with unresectable chemotherapy-refractory metastatic colorectal cancer and primary hepatobiliary tumors, compared with historical controls. It is suggested that the route of TAI has obvious advantages over systemic chemotherapy in increasing the antitumor effect with lower toxicity to normal tissue. Another study 10 evaluated the outcomes of patients with advanced hepatic hilar duct carcinoma who received external beam radiotherapy combined with TAI of chemotherapy and a vasoconstrictor. Biliary endoprosthesis resolved the obstruction completely in 1 of the 22 patients.
No report can be found on the treatment of extrahepatic biliary tumor with TAI combined with 3DCRT. We have sequentially applied TAI and 3DCRT to achieve short-term efficacy in reducing the primary and metastatic lesions and of abolishing completely the obstruction with a lower total dosage of radiation [8] [9] [10] and a different regimen of TAI. 9,10 Such a combination of allied drugs was thought to be more effective for cholangiocarcinoma because cisplatin is non-cell cycle specific and DNA targeting, tegafur is S phase specific and interferes with synthesis of DNA and RNA, and vinorelbine is M phase specific and impedes the formation of microtubules. Also, the effect may contribute to a local high concentration of chemical treatments by TAI, both shrinking the tumor and rendering it more sensitive to radiation. Drug concentration is dozens to 100 times higher at the local lesion by arterial infusion than by venous infusion, which has the disadvantage of being diluted first by the systemic blood volume. In addition, there are subsequent venous chemotherapy effects when the arterially administered drugs get into the systemic circulation. 11, 12 The fever presenting after placement of the drainage tube may be caused by inadequate drainage at first and toxin absorption promoted by the higher inner pressure of the biliary tract; it can be relieved with prompt flushing of the tube.
In conclusion, this case report proposes that complete common bile duct obstruction caused by cholangiocarcinoma could be treated with TAI followed by 3DCRT and that responses are possible and perhaps even durable. Longterm effects need more cases and further observation.
